Clinical trial

Comparing 3 Schedules of Alimta Plus Gemzar

NCT00034606

StatusCOMPLETED

Study typeINTERVENTIONAL

Start dateUnknown

PhasePHASE2

Study timeline

Registry last updated2006-07-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Carcinoma, Non-Small-Cell Lungunresolved

Lung Neoplasmsunresolved

Neoplasmsunresolved

Interventions

Pemetrexed (Alimta) in combination with gemcitabine (Gemzar)DRUG

Sponsors & collaborators

Eli Lilly and Companylead sponsor

Mapped research locations

RochesterMinnesota, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00034606 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.